These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 26402485)

  • 1. Meta-Analysis: Reduced Risk of Anxiety with Psychostimulant Treatment in Children with Attention-Deficit/Hyperactivity Disorder.
    Coughlin CG; Cohen SC; Mulqueen JM; Ferracioli-Oda E; Stuckelman ZD; Bloch MH
    J Child Adolesc Psychopharmacol; 2015 Oct; 25(8):611-7. PubMed ID: 26402485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Meta-Analysis: Risk of Tics Associated With Psychostimulant Use in Randomized, Placebo-Controlled Trials.
    Cohen SC; Mulqueen JM; Ferracioli-Oda E; Stuckelman ZD; Coughlin CG; Leckman JF; Bloch MH
    J Am Acad Child Adolesc Psychiatry; 2015 Sep; 54(9):728-36. PubMed ID: 26299294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of Irritability With Psychostimulant Treatment in Children With ADHD: A Meta-Analysis.
    Stuckelman ZD; Mulqueen JM; Ferracioli-Oda E; Cohen SC; Coughlin CG; Leckman JF; Bloch MH
    J Clin Psychiatry; 2017 Jun; 78(6):e648-e655. PubMed ID: 28682529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A controlled trial of extended-release guanfacine and psychostimulants for attention-deficit/hyperactivity disorder.
    Wilens TE; Bukstein O; Brams M; Cutler AJ; Childress A; Rugino T; Lyne A; Grannis K; Youcha S
    J Am Acad Child Adolesc Psychiatry; 2012 Jan; 51(1):74-85.e2. PubMed ID: 22176941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Guanfacine extended release as adjunctive therapy to psychostimulants in children and adolescents with attention-deficit/hyperactivity disorder.
    Childress AC
    Adv Ther; 2012 May; 29(5):385-400. PubMed ID: 22610723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Attention deficit hyperactivity disorder: anxiety phenomena in children treated with psychostimulant medication for 6 months or more.
    Vance AL; Luk ES; Costin J; Tonge BJ; Pantelis C
    Aust N Z J Psychiatry; 1999 Jun; 33(3):399-406. PubMed ID: 10442797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Response/remission with guanfacine extended-release and psychostimulants in children and adolescents with attention-deficit/hyperactivity disorder.
    Cutler AJ; Brams M; Bukstein O; Mattingly G; McBurnett K; White C; Rubin J
    J Am Acad Child Adolesc Psychiatry; 2014 Oct; 53(10):1092-101. PubMed ID: 25245353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relationship between tourette syndrome, attention deficit hyperactivity disorder, and stimulant medication: a critical review.
    Erenberg G
    Semin Pediatr Neurol; 2005 Dec; 12(4):217-21. PubMed ID: 16780292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of the efficacy of medications for adult attention-deficit/hyperactivity disorder using meta-analysis of effect sizes.
    Faraone SV; Glatt SJ
    J Clin Psychiatry; 2010 Jun; 71(6):754-63. PubMed ID: 20051220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of modafinil film-coated tablets in children and adolescents with attention-deficit/hyperactivity disorder: results of a randomized, double-blind, placebo-controlled, flexible-dose study.
    Biederman J; Swanson JM; Wigal SB; Kratochvil CJ; Boellner SW; Earl CQ; Jiang J; Greenhill L
    Pediatrics; 2005 Dec; 116(6):e777-84. PubMed ID: 16322134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transition from methylphenidate or amphetamine to atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder--a preliminary tolerability and efficacy study.
    Quintana H; Cherlin EA; Duesenberg DA; Bangs ME; Ramsey JL; Feldman PD; Allen AJ; Kelsey DK
    Clin Ther; 2007 Jun; 29(6):1168-77. PubMed ID: 17692731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risperidone effects in the presence/absence of psychostimulant medicine in children with ADHD, other disruptive behavior disorders, and subaverage IQ.
    Aman MG; Binder C; Turgay A
    J Child Adolesc Psychopharmacol; 2004; 14(2):243-54. PubMed ID: 15319021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychostimulants in preschool children with attention-deficit/hyperactivity disorder: clinical evidence from a developmental disorders institution.
    Ghuman JK; Ginsburg GS; Subramaniam G; Ghuman HS; Kau AS; Riddle MA
    J Am Acad Child Adolesc Psychiatry; 2001 May; 40(5):516-24. PubMed ID: 11349695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Attention deficit hyperactivity disorder and anxiety: is there an association with neurodevelopmental deficits?
    Vance AL; Luk ES
    Aust N Z J Psychiatry; 1998 Oct; 32(5):650-7. PubMed ID: 9805587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and tolerability of psychostimulants for symptoms of attention-deficit hyperactivity disorder in preschool children: A systematic review and meta-analysis.
    Chiu HJ; Sun CK; Cheng YS; Wang MY; Tzang RF; Lin FL; Cheng YC; Chung W
    Eur Psychiatry; 2023 Feb; 66(1):e24. PubMed ID: 36788670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modafinil for the treatment of attention-deficit/hyperactivity disorder: A meta-analysis.
    Wang SM; Han C; Lee SJ; Jun TY; Patkar AA; Masand PS; Pae CU
    J Psychiatr Res; 2017 Jan; 84():292-300. PubMed ID: 27810669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atomoxetine versus stimulants for treatment of attention deficit/hyperactivity disorder.
    Gibson AP; Bettinger TL; Patel NC; Crismon ML
    Ann Pharmacother; 2006 Jun; 40(6):1134-42. PubMed ID: 16735655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Developmental aspects of psychostimulant treatment in children and adolescents with attention-deficit/hyperactivity disorder.
    Findling RL; Short EJ; Manos MJ
    J Am Acad Child Adolesc Psychiatry; 2001 Dec; 40(12):1441-7. PubMed ID: 11765290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
    Spencer TJ; Wilens TE; Biederman J; Weisler RH; Read SC; Pratt R
    Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Onset of efficacy of long-acting psychostimulants in pediatric attention-deficit/hyperactivity disorder.
    Brams M; Mao AR; Doyle RL
    Postgrad Med; 2008 Sep; 120(3):69-88. PubMed ID: 18824827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.